| [1] |
World Health Organization. Global tuberculosis report 2025[R]. Geneva: World Health Organization, 2025.
|
| [2] |
Dreesman A, Dirix V, Smits K, et al. Identification of Mycobacterium tuberculosis Infection in Infants and Children With Partial Discrimination Between Active Disease and Asymptomatic Infection[J]. Front Pediatr, 2019, 7: 311. doi:10.3389/fped.2019.00311.
|
| [3] |
Jenkins H E, Yuen C M, Rodriguez C A, et al. Mortality in children diagnosed with tuberculosis: a systematic review and meta-analysis[J]. Lancet Infect Dis, 2017, 17(3): 285-295. doi:10.1016/S1473-3099(16)30474-1.
pmid: 27964822
|
| [4] |
Velasco-Arnaiz E, Soriano-Arandes A, Latorre I, et al. Performance of tuberculin skin tests and interferon-γ release assays in children younger than 5 years[J]. Pediatr Infect Dis J, 2018, 37(12): 1235-1241. doi:10.1097/INF.0000000000002015.
pmid: 30408005
|
| [5] |
Ahmed A, Feng P I, Gaensbauer J T, et al. Interferon-γ release assays in children<15 years of age[J]. Pediatrics, 2020, 145(1): e20191930. doi:10.1542/peds.2019-1930.
|
| [6] |
Seo Y S, Kang J M, Kim D S, et al. Xpert MTB/RIF assay for diagnosis of extrapulmonary tuberculosis in children: a systematic review and meta-analysis[J]. BMC Infect Dis, 2020, 20(1): 14. doi:10.1186/s12879-019-4745-1.
pmid: 31906996
|
| [7] |
Srivastava S, Battu M B, Khan M Z, et al. Mycobacterium tuberculosis PPE2 protein interacts with p67phox and inhibits reactive oxygen species production[J]. J Immunol, 2019, 203(5): 1218-1229. doi:10.4049/jimmunol.1801143.
pmid: 31375544
|
| [8] |
Li J, Sun L, Sheng A, et al. Characterization of plasma proteins in children of different Mycobacterium tuberculosis infection status using label-free quantitative proteomics[J]. Oncotarget, 2017, 8 (61): 103290-103301. doi:10.18632/oncotarget.21179.
|
| [9] |
Koda T, Namba A, Kinoshita M, et al. Sema4A is implicated in the acceleration of Th17 cell-mediated neuroinflammation in the effector phase[J]. J Neuroinflammation, 2020, 17(1): 82. doi:10.1186/s12974-020-01757-w.
|
| [10] |
Cavalcanti C A J, Germoglio V, de Azevedo Silva J, et al. T-cell specific upregulation of Sema4A as risk factor for autoimmunity in systemic lupus erythematosus and rheumatoid arthritis[J]. Autoimmunity, 2020, 53(2): 65-70. doi:10.1080/08916934.2019.1704273.
pmid: 31876207
|
| [11] |
中华医学会结核病学分会儿童结核病专业委员会, 中国研究型医院学会结核病学专业委员会, 国家呼吸系统疾病临床医学研究中心, 等. 儿童肺结核诊断专家共识[J]. 中华实用儿科临床杂志, 2022, 37(7): 490-496. doi:10.3760/cma.j.cn101070-20211207-01436.
|
| [12] |
中华医学会结核病学分会儿童结核病专业委员会, 国家儿童医学中心, 首都医科大学附属北京儿童医院, 等. 儿童结核分枝杆菌潜伏感染筛查和预防性治疗专家共识[J]. 中华结核和呼吸杂志, 2020, 43(4): 345-349. doi:10.3760/cma.j.cn112147-20200106-00006.
|
| [13] |
李静, 姜琦, 江渊. PCR荧光探针技术对结核分枝杆菌复合群及利福平耐药性检测性能的评价[J]. 中国防痨杂志, 2024, 46(10): 1250-1258. doi:10.19982/j.issn.1000-6621.20240166.
|
| [14] |
贾涤静, 安晓颖, 刘美, 等. TB-LAMP 联合细胞因子IL-2和IFN-γ对活动性肺结核的诊断价值[J]. 中华医院感染学杂志, 2026, 36(8): 1222-1227. doi:10.11816/cn.ni.2026-252624.
|
| [15] |
张丽帆, 刘晓清. 诊断试验准确性研究设计及临床应用[J]. 协和医学杂志, 2020, 11(1): 96-101. doi:10.3969/j.issn.1674-9081.20190276.
|
| [16] |
Ligon L S, Hayden J D, Braunstein M. The ins and outs of Mycobacterium tuberculosis protein export[J]. Tuberculosis (Edinb), 2012, 92(2): 121-132. doi:10.1016/j.tube.2011.11.005.
|
| [17] |
Kamolratanakul S, Ariyanon W, Udompornpitak K, et al. Comparison of the Single Cell Immune Landscape between Subjects with High Mycobacterium tuberculosis Bacillary Loads during Active Pulmonary Tuberculosis and Household Members with Latent Tuberculosis Infection[J]. Cells, 2024, 13(4): 362. doi:10.3390/cells13040362.
|
| [18] |
Naito Y, Koyama S, Masuhiro K, et al. Tumor-derived semaphorin 4A improves PD-1-blocking antibody efficacy by enhancing CD8+ T cell cytotoxicity and proliferation[J]. Sci Adv, 2023, 9(20): eade0718. doi:10.1126/sciadv.ade0718.
|
| [19] |
Ito D, Kumanogoh A. The role of Sema4A in angiogenesis, immune responses, carcinogenesis, and retinal systems[J]. Cell Adh Migr, 2016, 10(6): 692-699. doi:10.1080/19336918.2016.1215785.
|
| [20] |
Martínez-Ramos S, Rafael-Vidal C, Malvar J, et al. Semaphorin4B is elevated in rheumatoid arthritis and enhances the inflammatory phenotype of macrophages and fibroblast-like synoviocytes[J]. Arthritis Res Ther, 2025, 27(1): 132. doi:10.1186/s13075-025-03592-x.
pmid: 40598553
|
| [21] |
Iyer A S, Chapoval S P. Neuroimmune Semaphorin 4A in Cancer Angiogenesis and Inflammation: A Promoter or a Suppressor?[J]. Int Mol Sci, 2018, 20(1): 124. doi:10.3390/ijms20010124.
|
| [22] |
Wei X, Liu Z, Shen Y, et al. Semaphorin4A promotes lung cancer by activation of NF-κB pathway mediated by PlexinB1[J]. Peer J, 2023, 11: e16292. doi:10.7717/peerj.16292.
|
| [23] |
Carvalheiro T, Affandi A J, Malvar-Fernández B, et al. Induction of inflammation and fibrosis by semaphorin 4A in systemic sclerosis[J]. Arthritis Rheumatol, 2019, 71(10): 1711-1722. doi:10.1002/art.40915.
|
| [24] |
Naito M, Kumanogoh A. The role of semaphorins in allergic diseases[J]. Allergol Int, 2024, 73(1): 31-39. doi:10.1016/j.alit.2023.08.006.
|
| [25] |
Rajabinejad M, Asadi G, Ranjbar S, et al. Semaphorin 4A, 4C, and 4D: Function Comparison in the Autoimmunity, Allergy, and Cancer[J]. Gene, 2020, 746: 144637. doi:10.1016/j.gene.2020.144637.
|
| [26] |
Keller C, Hoffmann R, Lang R, et al. Genetically determined susceptibility to tuberculosis in mice causally involves accelerated and enhanced recruitment of granulocytes[J]. Infect Immun, 2006, 74(7): 4295-4309. doi:10.1128/IAI.00057-06.
pmid: 16790804
|
| [27] |
Wang L, Song G, Zheng Y, et al. Expression of Semaphorin 4A and its potential role in rheumatoid arthritis[J]. Arthritis Res Ther, 2015, 17(1): 227. doi:10.1186/s13075-015-0734-y.
|
| [28] |
Eiza N, Garty M, Staun-Ram E, et al. The possible involvement of sema3A and sema4A in the pathogenesis of multiple sclerosis[J]. Clin Immunol, 2022, 238: 109017. doi:10.1016/j.clim.2022.109017.
|